UPLOAD Filing
GeoVax Labs, Inc.
Date: April 17, 2026 · CIK: 0000832489 · Accession: 0000000000-26-003924
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-295081
Letter
Re: GeoVax Labs, Inc. Registration Statement on Form S-1 Filed April 16, 2026 File No. 333-295081 Dear David A. Dodd:
April 17, 2026
David A. Dodd President & Chief Executive Officer GeoVax Labs, Inc. 1955 Lake Park Drive, Suite 300 Smyrna, Georgia 30080
This is to advise you that we have not reviewed and will not review your registration statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Chris Edwards at 202-551-6761 with any questions.
Sincerely,
Division of
Corporation Finance
Office of Life
Sciences
cc: F. Reid Avett, Esq.
Show Raw Text
<DOCUMENT> <TYPE>TEXT-EXTRACT <SEQUENCE>2 <FILENAME>filename2.txt <TEXT> April 17, 2026 David A. Dodd President & Chief Executive Officer GeoVax Labs, Inc. 1955 Lake Park Drive, Suite 300 Smyrna, Georgia 30080 Re: GeoVax Labs, Inc. Registration Statement on Form S-1 Filed April 16, 2026 File No. 333-295081 Dear David A. Dodd: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Chris Edwards at 202-551-6761 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: F. Reid Avett, Esq. </TEXT> </DOCUMENT>